GPR37 and Alzheimer disease: Furthermore, the ecto-GPR37 peptides are significantly increased in the cerebrospinal fluid (CSF) of PD patients but not increased in the CSF of Alzheimer’s disease patients, suggesting that ecto-GPR37 may serve as a potential biomarker for PD [50].